Balyasny Asset Management L.P.
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1218710
Chicago, IL
Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,170,246
-$2,243,188 QoQ
Shares Held
169,286
-33.8% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Dec 31, 2024CallValue
$5,737,886
CallShares
492,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. NTLA ranks #116 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,779,445 | $146,532,340 | |
| 2 | ERAS |
Erasca, Inc.
|
5,143,985 | $83,229,677 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
3,826,659 | $80,053,706 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,917,501 | $77,141,065 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,362,752 | $76,981,860 | |
| 6 | CYTK |
Cytokinetics Inc
|
992,545 | $65,418,640 | |
| 7 | DAWN |
Day One Biopharmaceuticals, Inc.
|
2,625,235 | $56,285,038 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,827,513 | $55,345,837 |
All Filings in NTLA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,170,246 | 169,286 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $4,413,434 | 255,555 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,301,682 | 1,311,480 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,772,254 | 1,515,085 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,891,388 | 2,306,294 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $5,737,886 | 492,100 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $15,409,643 | 749,861 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,776,669 | 347,483 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,185,662 | 188,501 | Shares | Sole | 2024-05-13 | |
| 2022-12-31 | $26,586 | 762 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $2,220,996 | 39,689 | Shares | Sole | 2022-11-15 | |
| 2022-09-30 | $559,600 | 10,000 | Call | Sole | 2022-11-15 | |
| 2021-03-31 | $3,107,473 | 38,720 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,525,699 | 83,193 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||